30 results
8-K
EX-99.1
OLMA
Olema Pharmaceuticals, Inc.
6 Aug 24
Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
4:10pm
program, as well as general and administrative activities. The increase was partially offset by higher interest income earned from marketable securities
8-K
EX-99.1
OLMA
Olema Pharmaceuticals, Inc.
8 May 24
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:06pm
of our KAT6 inhibitor program. This increase was offset by decreased spending on general and administrative activities and higher interest income … into late-stage clinical trials. The increase was offset by decreased spending on clinical pharmacology studies and nonclinical research programs
8-K
EX-99.1
rr66k0
11 Mar 24
Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
cy0 tohrz
7 Nov 23
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
0syz3970qdwh518 xjo
8 Aug 23
Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-99.1
2q4sfz 9fq3fzcr
9 May 23
Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
10-Q
ueuk44
11 May 21
Quarterly report
4:22pm